Vioxx makers knew of heart risks sooner
A story today on the Wall Street Journal says that Vioxx makers Merck & Co knew of the heart risks for the pain killer much sooner than the company claimed.
Merck withdrew Vioxx from the market in September 2004 after a study showed the one-time $2.5 billion-a-year drug doubled the risk of heart problems after 18 months of use. The company has since argued in trials that there is no evidence that short-term use increased heart risks.
Read the story at wsj.com
